| Literature DB >> 29534082 |
Hannah Crocker Cunningham1, Kristi M Cammack1,2, Kristin E Hales3, Harvey C Freetly3, Amanda K Lindholm-Perry3.
Abstract
Feed costs account for over 70% of the annual expenditures in cow/calf production. During the production year the cow uses nutrients to support conceptus growth, milk production, work (grazing and locomotion), and maintenance requirements. The majority of the nutrients are used to support maintenance. Substrate cycling has been identified as one of the major contributors toward energy expenditure associated with maintenance in mature cows. The objective of this study was to determine whether beef cows that differ in the efficiency of weight gain differ in the relative abundance of transcripts for metabolic regulation in adipose tissue. Mature beef cows were subjected to feed restriction followed by ad libitum feed. Adipose tissue from twelve cows with high (n = 6) and low (n = 6) gain based on growth performance during the ad libitum feeding period was evaluated for transcriptome expression differences. A total of 496 genes were differentially expressed and passed Bonferroni correction for the animals with greater gain between restriction and realimentation and 491 genes were differentially expressed among animals with lesser gains between feed restriction and realimentation. Of these two differentially expressed gene lists, 144 genes were common between animals with greater and those with lesser gain. Enriched biological processes included the TCA cycle, oxidative phosphorylation, respiratory electron transport chain and fatty acid metabolic processes. Specific to adipose tissue of low gaining animals was glycolysis and to high gain animals was coenzyme, steroid, cellular amino acid, nitrogen compound metabolic processes, and sensory perception. The oxidative phosphorylation, mitochondrial dysfunction and cholesterol biosynthesis pathways were commonly associated with the high gain animals between feed restriction and realimentation, as well as with the low gaining animals between the two time points. Unique to the high gaining animals were valine degradation and LPS/IL-1 mediated inhibition of RXR function pathways. In this discovery study, genes involved in lipid metabolism, mitochondrial respiration and oxidative phosphorylation pathways appear to be critical to mature cows during times of abundant feed after feed restriction.Entities:
Mesh:
Year: 2018 PMID: 29534082 PMCID: PMC5849288 DOI: 10.1371/journal.pone.0194104
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Body weight gain of cows with greater gain or lesser gain.
Biological processes over-represented among the list of DEG (P < 0.05) identified in adipose tissue after feed restriction and realimentation for cows with greater body weight gain.
| Term | # Identified | # Expected | Fold Enrichment | Bonferroni Corrected |
|---|---|---|---|---|
| Tricarboxylic acid cycle | 12 | 2.6 | 4.6 | 4.43E-03 |
| Oxidative Phosphylation | 26 | 6.5 | 4 | 1.30E-06 |
| Respiratory ETC | 40 | 16.8 | 2.4 | 2.18E-04 |
| Coenzyme metabolic process | 26 | 11 | 2.4 | 1.99E-02 |
| Fatty Acid Metabolic Process | 39 | 19 | 2 | 8.01E-03 |
| Steroid Metabolic Process | 37 | 18.5 | 2 | 2.29E-02 |
| Cellular Amino Acid Metabolic Process | 50 | 26.6 | 1.88 | 6.76E-03 |
| Nitrogen Compound Metabolic Process | 255 | 205 | 1.25 | 4.42E-02 |
| Sensory Perception of Smell | 30 | 69.5 | 0.43 | 1.27E-05 |
1 Biological process enriched for in the list of DEG genes.
2 Number of DEG identified within the biological process.
3 The number of genes that expected based on the reference genes.
4 Fold Enrichment of the genes observed in the list of DEG genes that is over the expected.
5 The biological process of sensory perception of smell was represented by fewer genes than expected.
Ingenuity pathway analysis of differentially expressed genes (P < 0.05) from adipose tissues from cows with greater gain between feed restriction and realimentation sample collection, and for cows with lesser gain between feed restriction and realimentation.
| Comparison | Top Canonical Pathway | #DEG Represented | |
|---|---|---|---|
| High Gain | Oxidative Phosphorylation | 3.27E-25 | 51 |
| Mitochondrial Dysfunction | 4.09E-21 | 63 | |
| Valine Degradation I | 1.01E-05 | 10 | |
| LPS/IL-1 Mediated Inhibition of RXR Function | 1.48E-05 | 45 | |
| Superpathway of Cholesterol Biosynthesis | 2.08E-05 | 12 | |
| Low Gain | Oxidative Phosphorylation | 1.04E-23 | 45 |
| Mitochondrial Dysfunction | 7.44E-22 | 57 | |
| Superpathway of Cholesterol Biosynthesis | 1.70E-07 | 13 | |
| Cholesterol Biosynthesis I | 3.55E-06 | 8 | |
| Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol) | 3.55E-06 | 8 |
Differentially expressed genes with mitochondrial energy production functions identified in cows with higher gain between feed restriction and realimentation.
| Gene | Gene Name | ETC Function | Fold Change | |
|---|---|---|---|---|
| ATP synthase alpha subunit 1, cardiac muscle | Complex V | 1.08 | 0.02 | |
| ATP synthase gamma polypeptide 1 | Complex V | 1.11 | 0.05 | |
| ATP synthase subunit B1 | Complex V | 1.09 | 0.009 | |
| ATP synthase subunit C3 (subunit 9) | Complex V | 1.17 | 0.02 | |
| ATP synthase subunit d | Complex V | 1.08 | 0.005 | |
| ATP synthase O subunit | Complex V | 1.11 | 0.02 | |
| ATPase inhibitory factor 1 | Complex V | 1.10 | 0.001 | |
| cytochrome c oxidase subunit VIIa polypeptide 2 (liver) | Complex IV | 1.12 | 0.007 | |
| NADH dehydrogenase 1 alpha subcomplex, 10 | Complex I | 1.20 | 0.008 | |
| NADH dehydrogenase 1 alpha subcomplex, 13 | Complex I | 1.18 | 0.0003 | |
| NADH dehydrogenase 1 alpha subcomplex, 2 | Complex I | 1.13 | 0.02 | |
| NADH dehydrogenase 1 alpha subcomplex, 4 | Complex I | 1.10 | 0.01 | |
| NADH dehydrogenase 1 beta subcomplex, 5 | Complex I | 1.15 | 0.0003 | |
| NADH dehydrogenase Fe-S protein 2 | Complex I | 1.11 | 0.02 | |
| NADH dehydrogenase Fe-S protein 5 | Complex I | 1.09 | 0.005 | |
| NADH dehydrogenase Fe-S protein 6 | Complex I | 1.13 | 0.05 | |
| succinate dehydrogenase complex, subunit D, integral membrane protein | Complex II | 1.12 | 0.0003 | |
| ubiquinol-cytochrome c reductase, complex III subunit XI | Complex III | 1.19 | 0.0005 | |
| ubiquinol-cytochrome c reductase hinge protein | Complex III | 1.11 | 0.02 | |
| TCA | 1.12 | 0.010 |
1 All genes in Complex I-V were also identified as differentially expressed in low gain animals, but they were not significant after correction for multiple testing, except for fumerate hydratase (FH) shown in bold, which was not identified as differentially expressed in low gain animals at P < 0.05.
2 Components of the TCA and oxidative phosphorylation pathways that each of the DEG is associated with.
3 Fold change is the log2 fold change difference between ad libitum and feed restriction studies. These genes were more highly transcribed during the ad libitum study.
4 The P shown was corrected by multiplying the nominal P by the number of genes tested (24,431).
Biological processes of over-represented among the list of DEG (P < 0.05) identified in adipose tissue after feed restriction and realimentation for cows with lower body weight gain.
| Term | # Identified | # Expected | Fold Enrichment | Nominal |
|---|---|---|---|---|
| Tricarboxylic Acid Cycle | 11 | 2 | 5.5 | 2.13E-03 |
| Oxidative Phosphorylation | 25 | 5 | 5 | 3.50E-08 |
| Glycolysis | 12 | 3 | 4 | 1.25E-02 |
| Respiratory Electron Transport Chain | 35 | 13 | 3 | 6.85E-05 |
| Fatty Acid Metabolic Process | 37 | 15 | 2.5 | 1.54E-04 |
1 Biological process enriched for in the list of DEG genes.
2 Number of DEG identified within the biological process.
3 The number of genes that expected based on the reference genes.
4 Fold Enrichment of the genes observed in the list of DEG genes that is over the expected.
Genes with biological functions in lipid metabolism pathways identified as differentially expressed for high and low gain animals.
| Gene | Gene Name | Fold Change Low Gain | Fold Change High Gain | ||
|---|---|---|---|---|---|
| acetyl-CoA carboxylase alpha | 4.58 | 0.000078 | 9.32 | ||
| acyl-CoA dehydrogenase, C-2 to C-3 short chain | 1.21 | 0.0019 | 2.60 | 0.000084 | |
| acyl-CoA dehydrogenase, short/branched chain | 1.04 | 0.0021 | 1.93 | 0.00039 | |
| acetyl-CoA acetyltransferase 1 | 1.05 | 0.0043 | 1.01 | 0.00069 | |
| acetyl-CoA acetyltransferase 2 | 2.11 | 0.00071 | 1.37 | 0.0019 | |
| ATP citrate lyase | 41.07 | 0.000035 | |||
| aconitase 2, mitochondrial | 1.47 | 0.012 | 2.17 | 0.00035 | |
| acyl-CoA oxidase 1, palmitoyl | 1.01 | 0.024 | |||
| acyl-CoA oxidase 2, branched chain | 2.19 | 0.00031 | 2.27 | 0.000065 | |
| acyl-CoA synthetase long-chain family member 1 | |||||
| acyl-CoA synthetase long-chain family member 4 | 1.10 | 0.0019 | 1.83 | 0.014 | |
| acyl-CoA synthetase long-chain family member 5; long-chain-fatty-acid—CoA ligase 5-like | 2.16 | 0.0033 | 1.27 | 0.020 | |
| acyl-CoA synthetase short-chain family member 2 | 4.20 | 0.00012 | |||
| acyl-CoA synthetase short-chain family member 3 | 1.06 | 0.071 | |||
| 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) | 2.00 | 0.0038 | 7.52 | 0.000087 | |
| aldehyde dehydrogenase 2 family (mitochondrial) | 1.20 | 0.0014 | 1.29 | 0.0013 | |
| aldolase A, fructose-bisphosphate | |||||
| angiopoietin-like 4 | 0.10 | 0.00035 | 0.07 | 0.00018 | |
| apolipoprotein E | 2.23 | 0.0096 | 1.75 | 0.011 | |
| carnitine palmitoyltransferase 1A (liver) | 0.07 | 0.00011 | |||
| carnitine palmitoyltransferase 1B (muscle) | 0.22 | 0.00086 | 0.21 | 0.00086 | |
| carnitine palmitoyltransferase 2 | 1.67 | 0.0016 | |||
| enoyl CoA hydratase, short chain, 1, mitochondrial | 2.31 | 0.00086 | |||
| enoyl-CoA delta isomerase 2 | 1.66 | 0.028 | 1.13 | 0.016 | |
| enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | 1.04 | 0.0054 | 1.58 | 0.0010 | |
| ELOVL fatty acid elongase 4 | |||||
| ELOVL fatty acid elongase 5 | 3.29 | 0.00016 | 4.29 | 0.00029 | |
| ELOVL fatty acid elongase 6 | 5.24 | 0.000085 | |||
| fatty acid binding protein 7, brain | 1.18 | 0.0084 | |||
| fatty acid synthase | 4.56 | 0.0016 | |||
| glucose-6-phosphate dehydrogenase | 2.16 | 0.00021 | |||
| glucose-6-phosphate isomerase | |||||
| lipoprotein lipase | 1.02 | 0.00053 | 1.26 | 0.00027 | |
| lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 3.14 | 0.00049 | 2.69 | 0.0012 | |
| phosphoenolpyruvate carboxykinase 1 (soluble) | 1.53 | 0.045 | 1.36 | 0.044 | |
| phosphoenolpyruvate carboxykinase 2 (mitochondrial) | 1.47 | 0.0031 | 5.24 | 0.000078 | |
| 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | 1.37 | 0.013 | 1.21 | 0.0018 |
1 Human genome organization gene nomenclature committee gene symbol.
2 Fold change is the log2 fold change difference between ad libitum and feed restriction studies. Genes with values > 1 were up-regulated during realimentation, genes with values < 1 were down-regulated. Fold changes and P-values in bold represent values that were significant after Bonferroni correction.